Recent News

• 04.16.2025 - ABVC BioPharma Announces 2024 Financial Results
• 04.04.2025 - ABVC’s Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
• 03.19.2025 - Wall Street Reporter: ABVC BioPharma CEO Interview with Uttam Patil
• 12.16.2024 - 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗧𝘄𝗼 𝗪𝗼𝗿𝗹𝗱𝘀: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗼𝗿 𝗔𝘀𝗽𝗶𝗿𝗶𝗻𝗴 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗮𝗻𝗱 𝗦𝘁𝘂𝗱𝗲𝗻𝘁𝘀 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗶𝗻𝗴 𝗧𝗮𝗶𝘄𝗮𝗻
• 11.14.2024 - ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

Recent Filings

• 04.16.2025 - 8-K/A Current report
• 04.15.2025 - EX-99.1 EX-99.1
• 04.15.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.15.2025 - 8-K Current report
• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 03.07.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.13.2025 - 8-K/A Current report
• 01.06.2025 - 8-K Current report
• 11.15.2024 - 424B4 Prospectus [Rule 424(b)(4)]